Skip to main content
Caplight Logo









Amplicore Inc.

Amplicore Inc.

Private
Mason, OhioHealthcare & Life Scienceshttps://www.amplicorepharma.com/

Last Round

Series A

Jul 1, 2022

Total Funding Raised

$6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amplicore Inc. is a biopharmaceutical company that develops injectable regenerative therapeutic drugs for musculoskeletal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Defense Tech

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicineinjectable therapeuticmusculoskeletal disordermeniscal tear repairtissue regenerationbiopharmaceuticalclinical stage pharmaorthopedicsosteoarthritis treatmentdegenerative disc diseaseminimally invasive treatmentcartilage repairsports medicineInvestigational New DrugINDDoD contractor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplicore Inc. Comparables

Compare Amplicore Inc. with similar companies based on industry and business-model similarity.

Amplicore Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DiscGenics
77%
Angitia Biopharmaceuticals
76%
Spine BioPharma, Inc.
73%

Amplicore Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2022
SeedMar 25, 2021

Key People

Founding team and executive leadership

Chia-Ying Lin

Founder, President CEO

Founding Team

Amplicore Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 64% MoM.

  • Mar 2, 2026

    Monthly visitors increased 49% MoM.

Amplicore Inc. Filings

Explore SEC and related filing metadata, where available.

Amplicore Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amplicore Inc.'s valuation, stock price, and market status.

Is Amplicore Inc. a public or private company?

Amplicore Inc. is a private company.

What is the current stock price of Amplicore Inc.?

Amplicore Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Amplicore Inc. worth (valuation)?

Valuation information for Amplicore Inc. is not publicly available.

Can I buy Amplicore Inc. stock?

Amplicore Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amplicore Inc.'s last funding round?

Amplicore Inc.'s most recent funding round was Series A on July 1, 2022.

Who are the main investors in Amplicore Inc.?

Key investors in Amplicore Inc. include Photon Fund.

Will Amplicore Inc. IPO soon?

No public IPO plans have been announced for Amplicore Inc..

How can I track Amplicore Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplicore Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMason, Ohio
Employee Range6
Year Founded2018
Last FundingJul 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?